Rigel Pharmaceuticals
RIGL
#6841
Rank
A$0.70 B
Marketcap
$39.87
Share price
3.99%
Change (1 day)
152.28%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): -A$10.31 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are A$0.13 Billion. In 2023 the company made an earning of -A$27.9 Million, an increase over its 2022 earnings that were of -A$84.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$10.31 Million-63.05%
2023 -A$27.9 Million-66.79%
2022 -A$84.01 Million340.73%
2021 -A$19.06 Million-56.15%
2020 -A$43.47 Million-57.34%
2019 -A$0.11 Billion-7.66%
2018 -A$0.12 Billion-9.47%
2017 -A$0.13 Billion24.46%
2016 -A$97.95 Million23.63%
2015 -A$79.22 Million-43.29%
2014 -A$0.14 Billion2.5%
2013 -A$0.14 Billion
2010 A$57.96 M-133.97%
2009 -A$0.18 Billion-18.49%
2008 -A$0.21 Billion71.91%
2007 -A$0.13 Billion84.74%
2006 -A$65.91 Million-10.17%
2005 -A$73.37 Million-15.73%
2004 -A$87.07 Million39.29%
2003 -A$62.51 Million10.3%
2002 -A$56.68 Million48.3%
2001 -A$38.22 Million-2.13%
2000 -A$39.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.2 Billion 1,902.15%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.32 Billion 3,065.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.39 B-144,236.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$7.16 B-71,830.80%๐Ÿ‡บ๐Ÿ‡ธ USA